Showing results (731-740 of 795) with videos related to

Sort By:
Pageof 80
Molecular and Biochemical Parasitology|May 12, 2009
Molecular characterisation of kappa-5, a major antigenic glycoprotein from Schistosoma mansoni eggsG Schramm, J V Hamilton, C I A Balog, et al.
Addiction (Abingdon, England)|February 7, 2023
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experimentWill Lawn, Katie Trinci, Claire Mokrysz, et al.
The Lancet. Psychiatry|June 17, 2026
International cannabis policies and their association with cannabis use, cannabis use disorder, and other psychiatric disordersTom P Freeman, Rachel Lees Thorne, Elle Wadsworth, et al.
Addiction (Abingdon, England)|June 6, 2022
Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances ActSam Craft, Michael Dunn, Dan Vidler, et al.
Biological Psychiatry|July 4, 2006
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderPaul E Keck, Jim Mintz, Susan L McElroy, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 23, 2025
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trialEdward Chesney, Dominic Oliver, Ananya Sarma, et al.
Geophysical Research Letters|June 16, 2015
Increases in plasma sheet temperature with solar wind driving during substorm growth phasesC Forsyth, C E J Watt, I J Rae, et al.
Brain Stimulation|October 15, 2017
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Psychopharmacology|April 21, 2022
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging studyMichael A P Bloomfield, Yumeya Yamamori, Chandni Hindocha, et al.
Pageof 80